European Psychiatry · 2012 · Unverified reference
Unverified citation — not used by the AI instructor.
Limitations: Bibliographic match not independently verified. Not used as support for clinical benefit.
Explore the library
Insufficient evidenceSynthetic tuftsin-related heptapeptide
Selank
Selank is a synthetic heptapeptide related to tuftsin. It is discussed in anxiety-related and neuropeptide research, but this edition could not independently match the supplied clinical citation.
Also indexed as: Tuftsin analog
A clear starting point
Selank is a synthetic heptapeptide related to tuftsin. It is discussed in anxiety-related and neuropeptide research, but this edition could not independently match the supplied clinical citation.
Systems mapping shows biological relevance, not a treatment recommendation or a patient CPI score.
No validated chemical structure is displayed in this edition.
How it works
Tuftsin-related / neuropeptide signaling
Selank is a synthetic heptapeptide related to tuftsin. It is discussed in anxiety-related and neuropeptide research, but this edition could not independently match the supplied clinical citation.
- Targets & processes
- Tuftsin-related / neuropeptide signaling
- Systems & tissues
- See the pathway description; category links describe research relevance, not demonstrated treatment effects.
What does the evidence show?
Anxiety-related signaling and neurobehavioral hypotheses.
What this does not establish
The supplied conference-style citation could not be independently verified. Independent replication and broadly applicable clinical outcome evidence are limited.
Citation metadata from PubMed, a service of the U.S. National Library of Medicine, NIH. A citation match is not a guarantee of study quality. Abstracts are not full-text reviews.
Safety is a separate question
FDA identifies insufficient safety information and possible immunogenicity and impurities. Interactions with psychiatric and sedative medicines are poorly characterized.
Contraindications & cautions
Not an exhaustive contraindication review. FDA identifies insufficient safety information and possible immunogenicity and impurities. Interactions with psychiatric and sedative medicines are poorly characterized.
Medication & supplement interactions
Interaction information is incomplete. FDA identifies insufficient safety information and possible immunogenicity and impurities. Interactions with psychiatric and sedative medicines are poorly characterized.
Regulatory status · United States
Not FDA-approved. No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Read the official sourceThis is not an exhaustive safety list. Regulatory status varies by jurisdiction and product; investigational use is not approval.
Make the science interactive
A dedicated lesson has not been published for this ingredient yet. Explore the cited profile or ask the instructor.
Your scientific classroom
Ask the IW Science Instructor
Basic level · Published sources only · AI evidence check
Ask about general science. Do not enter names, personal health details or medication lists. This is not a clinical consultation. Discussion stays in this browser’s private learning session for up to 90 days.
All medications and therapies discussed are for educational purposes only. Prescriptions are determined independently by the licensed clinician following a medical evaluation. There is no guarantee that any medication or peptide will be prescribed.
IW Interactive Learning Engine · Adapted from stable OpenMAIC v1.2.1. Open-source license
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.